MRKR Insider Trading
Insider Ownership Percentage: 5.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Marker Therapeutics Share Price & Price History
Current Price: $1.75
Price Change: +0.30 (1.20%)
As of 04/10/2026 05:00 PM ET
Marker Therapeutics Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/23/2024 | Enterprise Associates 16 New | Major Shareholder | Buy | 554,250 | $3.20 | $1,773,600.00 | 1,625,678 |  |
| 12/23/2024 | Steve Elms | Director | Buy | 11,085 | $3.20 | $35,472.00 | 325,370 | |
| 3/16/2023 | Norman David Eansor | Director | Buy | 14,285 | $17.50 | $249,987.50 | 16,713 | |
Marker Therapeutics Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/18/2026 | NewEdge Advisors LLC | 149,000 | $0.22M | 0.0% | N/A | 0.894% |  |
| 2/18/2026 | XTX Topco Ltd | 58,041 | $86K | 0.0% | +166.6% | 0.348% | |
| 2/17/2026 | Osaic Holdings Inc. | 94,421 | $0.14M | 0.0% | +16.5% | 0.566% | |
| 2/12/2026 | Jane Street Group LLC | 40,518 | $60K | 0.0% | N/A | 0.243% | |
| 2/12/2026 | Renaissance Technologies LLC | 123,650 | $0.18M | 0.0% | +16.4% | 0.742% | |
| 2/11/2026 | LPL Financial LLC | 83,247 | $0.12M | 0.0% | +41.7% | 0.499% | |
| 2/9/2026 | Geode Capital Management LLC | 130,344 | $0.19M | 0.0% | +35.3% | 0.782% | |
| 1/30/2026 | Boyer Financial Services Inc. | 36,817 | $57K | 0.1% | N/A | 0.221% | |
| 11/14/2025 | Virtu Financial LLC | 28,329 | $25K | 0.0% | N/A | 0.219% | |
| 11/14/2025 | Two Sigma Investments LP | 36,540 | $33K | 0.0% | N/A | 0.282% | |
| 8/14/2025 | Jane Street Group LLC | 21,800 | $33K | 0.0% | N/A | 0.193% | |
| 5/16/2025 | Alyeska Investment Group L.P. | 261,777 | $0.32M | 0.0% | -71.4% | 2.314% | |
| 2/17/2025 | NEA Management Company LLC | 1,625,678 | $5.06M | 0.3% | +51.7% | 15.179% | |
| 2/17/2025 | Millennium Management LLC | 16,108 | $50K | 0.0% | N/A | 0.150% | |
| 2/17/2025 | Alyeska Investment Group L.P. | 915,591 | $2.85M | 0.0% | N/A | 8.549% | |
| 2/14/2025 | Northern Trust Corp | 54,156 | $0.17M | 0.0% | +66.9% | 0.506% | |
| 2/14/2025 | Blue Owl Capital Holdings LP | 554,250 | $1.72M | 0.4% | N/A | 5.175% | |
| 2/12/2025 | Aisling Capital Management LP | 325,370 | $1.01M | 0.4% | +3.5% | 3.038% | |
| 2/11/2025 | LPL Financial LLC | 79,730 | $0.25M | 0.0% | N/A | 0.744% | |
| 11/19/2024 | Invst LLC | 20,000 | $56K | 0.0% | N/A | 0.224% | |
| 8/7/2024 | Wedbush Securities Inc. | 69,500 | $0.38M | 0.0% | +52.7% | 0.779% | |
| 1/24/2024 | International Assets Investment Management LLC | 11,000 | $60K | 0.0% | +1,000.0% | 0.124% | |
| 10/12/2023 | Matrix Asset Advisors Inc. NY | 15,000 | $68K | 0.0% | -62.5% | 0.170% | |
| 7/27/2023 | Virtu Financial LLC | 20,472 | $63K | 0.0% | N/A | 0.233% | |
| 7/18/2023 | Matrix Asset Advisors Inc. NY | 40,000 | $0.12M | 0.0% | +60.0% | 0.455% | |
| 5/17/2023 | Long Focus Capital Management LLC | 146,100 | $0.10M | 0.0% | -90.0% | 1.660% | |
| 5/12/2023 | Long Focus Capital Management LLC | 68,400 | $49K | 0.0% | -95.3% | 0.777% | |
| 5/9/2023 | Aisling Capital Management LP | 314,286 | $0.22M | 0.1% | -90.0% | 3.571% | |
| 5/9/2023 | AR Asset Management Inc. | 40,700 | $29K | 0.0% | N/A | 0.463% | |
| 1/19/2023 | Matrix Asset Advisors Inc. NY | 250,000 | $68K | 0.0% | -37.5% | 0.299% | |
| 11/15/2022 | Long Focus Capital Management LLC | 1,461,000 | $0.54M | 0.1% | -40.0% | 1.748% | |
| 10/25/2022 | Raymond James & Associates | 94,000 | $35K | 0.0% | N/A | 0.112% | |
| 10/24/2022 | Matrix Asset Advisors Inc. NY | 400,000 | $0.15M | 0.0% | +60.0% | 0.478% | |
| 7/15/2022 | Matrix Asset Advisors Inc. NY | 250,000 | $83K | 0.0% | +66.7% | 0.299% | |
| 5/10/2022 | AR Asset Management Inc. | 279,000 | $0.12M | 0.0% | +290.2% | 0.336% | |
| 4/19/2022 | Wedbush Securities Inc. | 90,068 | $40K | 0.0% | +44.0% | 0.108% | |
| 2/15/2022 | Kennedy Capital Management Inc. | 590,118 | $0.56M | 0.0% | -3.5% | 0.710% | |
| 2/14/2022 | Long Focus Capital Management LLC | 1,233,257 | $1.17M | 0.2% | N/A | 1.484% | |
| 2/10/2022 | Matrix Asset Advisors Inc. NY | 150,000 | $0.14M | 0.0% | N/A | 0.181% | |
| 2/10/2022 | Acadian Asset Management LLC | 39,507 | $37K | 0.0% | N/A | 0.048% | |
| 2/7/2022 | Victory Capital Management Inc. | 621,670 | $0.59M | 0.0% | -31.4% | 0.748% | |
| 2/7/2022 | AR Asset Management Inc. | 71,500 | $68K | 0.0% | -74.4% | 0.086% | |
| 2/3/2022 | ACT Capital Management LLC | 354,400 | $0.34M | 0.2% | -19.3% | 0.427% | |
Data available starting January 2016
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Read More on Marker Therapeutics
Volume
194,055 shs
Average Volume
147,800 shs
Market Capitalization
$29.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.47
Who are the company insiders with the largest holdings of Marker Therapeutics?
Marker Therapeutics' top insider shareholders include:
- John Robert Wilson (Director)
- Juan Vera (Insider)
- Enterprise Associates 16 New (Major Shareholder)
- Peter L Hoang (CEO)
- Steve Elms (Director)
- Norman David Eansor (Director)
- Frederick Gerald Wasserman (Director)
- Paul Edward Walker (Major Shareholder)
- Peter L Hoang (Insider)
Learn More about top insider investors at Marker Therapeutics.
Marker Therapeutics Active Insiders
